62.3 🩺 內科專科考前版

62.3.0.1 📌 䞀頁重點

  • 22E: rituximab first-line PV (Ritux + Pred), dupilumab BP refractory
  • Taiwan: 健保 rituximab for PV / refractory BP

62.3.0.2 🌟 Pearls (8)

  1. PV Ritux + Pred > Pred alone (Lancet 2017)
  2. BP topical clobetasol for mild (BP-FREE)
  3. Dupilumab for refractory BP (22E new)
  4. Behçet’s HLA-B51 in 亞掲 / 䞭東
  5. Pemphigus foliaceus mucosa spared (Dsg1 only)
  6. Paraneoplastic pemphigus = lymphoma association
  7. Cicatricial pemphigoid ophthalmology referral mandatory
  8. DH 6 個月 gluten-free before assess

62.3.0.3 📍 Taiwan

  • 健保 rituximab for PV
  • IVIG for refractory autoimmune blistering
  • Dupilumab BP 自費

62.3.0.4 🎓 內專重點

  1. PV vs BP 機蜉 + DIF
  2. Treatment evolution (Ritux first-line PV)
  3. Drug-induced (linear IgA)
  4. Behçet’s criteria
  5. Vasculitis skin

⚠ AI 草皿。